Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer

Figure 2

Kaplan–Meier plots of overall survival and disease-free survival of hepatoid adenocarcinoma (HAS) and alpha-fetoprotein-positive gastric cancer (AFPGC). Overall survival (a) outcomes were significantly worse in patients with AFPGC than in patients with HAS. Disease-free survival (b) outcomes revealed no significant difference between patients with HAS and patients with AFPGC. (c, d) Based on a cutoff value of 100 ng/mL of AFP in the HAS, there was statistically significant survival difference in OS (c), but there was no statistically significant survival difference in DFS (d).

(a)

(b)

(c)

(d)